
Demetri Maxim
Demetri Maxim
CLASS OF 2025
COMPANY
Nephrogen
Founder & CEO
LOCATION
New York
AREA OF FOCUS
AAV gene therapy, CRISPR-Cas genome editing
BIO
Demetri Maxim is the Founder and CEO of Nephrogen and has been actively immersed in kidney disease research since he was 14 years old. He completed his undergraduate and graduate research training at Stanford University under the mentorship of Vivek Bhalla, and world-renowned virologist, Mark Kay. Demetri also formerly worked in Dr. George Church’s lab at Harvard Medical School. Demetri’s family has kidney disease, and he founded Nephrogen based on his graduate research to develop an outright cure for kidney disease.